Yuki Imaoka, Japan
IL-37 Enhances Immunotherapeutic Potential of Off-the-Shelf Liver NK Cells for Hepatocellular Carcinoma: Overcoming Cryopreservation Challenges

Sabrina Leo, Canada
Retinoid Acid Receptor-Related Orphan Receptor Gamma (RORγ): A Potential Target in Transplantation Oncology to Expand Therapeutic Options for Patients with Hepatocellular Carcinoma (HCC)

Zijie Zhang, People's Republic of China
Integrative Multi-Omics Analysis Identifies Evolving Landscape and Potential Targets for Recurrent HCC After Liver Transplant

Allison Kwong, United States
Fewer Liver Transplant Recipients with HCC Are Waiting ≥6 Months for Transplant in the United States

Jin-Chiao Lee, Taiwan
Risk Stratification Based on Non-Transplantable Recurrence for Treatment Allocation in Child-Pugh A Patients with Hepatocellular Carcinoma

Jiyoung Kim, Korea
Post-Transplant Malignancy Risk in Liver Transplantation Recipients: A Nationwide Matched Cohort Study Comparing Liver Cancer and Non-Cancer Recipients with the General Population

Matthew Byrne, United States
Tumor Biology-Driven Recipient Selection Determines Outcomes in Liver Transplantation for Colorectal Liver Metastases